Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2Phase 2 1

Status

Terminated 2Unknown 1Completed 1Active not recruiting 1

Sponsor Class

NIH 11INDUSTRY 6OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 11CNS 10Breast 8Gastrointestinal 5Sarcoma 4Other hematologic neoplasm 2Head & Neck 2Dermatologic 2Tumor-Agnostic 1Myeloid 1Lymphoid 1Endocrine 1

Conditions

Gallbladder Neoplasms 2Recurrence 1Rectal Neoplasms 1Pancreatic Neoplasms 1Liver Neoplasms 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × AZD 6244 × Gastrointestinal × Clear all
NCT02151084 2025-12-16

A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer

University Health Network, Toronto

Phase 2 Active not recruiting
57 enrolled
Gastrointestinal

Gallbladder Neoplasms, Recurrence

NCT01160926 2023-04-24

DREAMtherapy

The Christie NHS Foundation Trust

Phase 1 Terminated
31 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02450656 2018-08-27

M14AFS

The Netherlands Cancer Institute

Phase 1/2 Unknown
320 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT01242605 2016-05-13

ABC-04

University College, London

Phase 1 Completed
13 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT01029418 2015-04-16

AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma

National Cancer Centre, Singapore

Phase 1/2 Terminated
30 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡